About Us

Bioocus Biotech Limited

Bioocus Biotech Limited focuses on the research and development of cellular immunotherapies. Bioocus is not only a leading biotech company in China, but also a whole-value-chain enterprise with self-owned research center, GMP facility, CDMO platform, and technology transferring platform. We have collaborated with renowned universities, research centers, and more than 20 hospitals all over the world.

Our goal is to bring cutting-edge cellular therapy to the world and make this valuable treatment accessible to patients worldwide.

About Us

Company Advantages

OUR GOAL IS TO PROVIDE THE MOST SUITABLE CELLULAR THERAPY FOR PATIENTS ALL OVER THE WORLD !

Research

By collaborating with the top-level universities in China, Bioocus has leading strength in production development field. Nowadays, Bioocus has 4 product lines and will continually extending.

CDMO Platform

Bioocus is willing to support other biotech facilities to obtain standard manufacturing.

We are open to collaborate with other biotech companies whose technology could bring effective treatment results to patients.

Manufacture

Bioocus has self-owned GMP-standard facility with total floor area of 7600m².

Technology Transfering

Bioocus keeps bringing cure hope to all patients. Therefore, we closely and actively cooperate with global hospitals, provide and transfer immune cell therapy technology to the world.

Patient Support

Our goal is to make the valuable treatment accessible to patients all over the world. Our medical tourism services are delivered to patients of China, India, Korea, Central Asia, Southeast Asia, the Middle East, South America, and Europe. We will gather global resources to support patients to get appropriate and affordable treatment.

Our Quality Control

Test report

High-tech Enterprises Certificate

Administrative Permit

Investment Record

Test Report

OUR INTRODUCTIONNIFDC AND BIOOCUS

The inspection report of cell quality testing issued by China National Institute for Food and Drug Control (CNIFDC) is the only standard for evaluating the cell quality system.

As one of the few companies in the country with a qualified report for the detection of cell value,Bioocus is an industry benchmark in terms of safety and effectiveness.

ABOUT US

Our Strategic Partners

Strategic partners are the most valuable resources to Bioocus. In 2022, Bioocus has officially signed strategic cooperation agreements with above 20 hospitals, joint clinical trials has been on the agenda. There will be more partners join Bioocus-leading projects in the future.

Inquiry for Pricelist

If you have any questions about our products or price list, please email us and we will contact you within 24 hours. Feel free to contact us if you are concerned about any aspect of your treatment details. Our medical team will give you professional, personalized treatment advice based on your actual situation.

click to submit an inquiry